BANK OF AMERICA CORP /DE/
BankPosition in EWTX — Edgewise Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in EWTX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$41,811,839
+$5,214,755 QoQ
Shares Held
1,327,360
-10.0% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 95.46573649951785.ToString("F0")%
Shared 0.ToString("F0")%
None 4.53426350048216.ToString("F0")%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. EWTX ranks #53 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in EWTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,811,839 | 1,327,360 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $36,597,084 | 1,474,797 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,208,758 | 321,132 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,335,561 | 254,429 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,299,372 | 695,426 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,305,815 | 48,907 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,221,879 | 308,051 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,913,018 | 272,794 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $980,636 | 53,763 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $681,210 | 62,268 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $236,224 | 41,226 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $405,332 | 52,301 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $364,000 | 54,573 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $470,064 | 52,580 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $130,211 | 13,233 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $317,747 | 39,918 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $267,234 | 27,550 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $439,849 | 28,786 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $45,483 | 2,740 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||